Chapter One — 1.1 Background to the Study

Over the past decade, the relationship between immunization coverage and disease prevalence has become a subject of considerable debate among scholars and industry practitioners alike, particularly within the context of Selected Family-Owned Businesses in Nigeria where operating conditions differ markedly from more developed markets.

Within the context of Selected Family-Owned Businesses in Nigeria, this relationship carries particular significance. Organizations in this setting operate under a distinct combination of economic, regulatory, and market conditions that may amplify or dampen the effect of immunization coverage on disease prevalence, making a context-specific inquiry both timely and necessary.

1.2 Statement of the Problem

Despite a growing body of literature on immunization coverage, there remains limited consensus on the precise nature of its relationship with disease prevalence, particularly within Selected Family-Owned Businesses in Nigeria. Many organizations continue to make decisions about immunization coverage without a clear, evidence-based understanding of how those decisions ultimately affect disease prevalence. This gap between practice and empirical understanding is the central problem this study seeks to address.

1.3 Objectives of the Study

1. To examine the effect of Immunization Coverage on disease prevalence in Selected Family-Owned Businesses in Nigeria.
2. To assess the extent to which immunization coverage influences disease prevalence within the study area.
3. To identify the challenges associated with immunization coverage in relation to disease prevalence.
4. To recommend strategies for optimizing immunization coverage in order to improve disease prevalence.

1.4 Research Questions

1. What is the effect of immunization coverage on disease prevalence in Selected Family-Owned Businesses in Nigeria?
2. To what extent does immunization coverage influence disease prevalence within the study area?
3. What challenges are associated with immunization coverage in relation to disease prevalence?
4. What strategies can be adopted to optimize immunization coverage in order to improve disease prevalence?

1.5 Significance of the Study

This study is significant to a range of stakeholders. For policymakers and regulators, the findings offer evidence to guide the design of frameworks that support healthier outcomes around disease prevalence. For managers and practitioners within Selected Family-Owned Businesses in Nigeria, the study provides practical insight into how immunization coverage can be better managed. Finally, it contributes to the academic literature on public health by extending existing knowledge into a specific empirical context, and offers a reference point for future researchers.

1.6 Scope of the Study

In terms of scope, this BSc study confines itself to Selected Family-Owned Businesses in Nigeria, focusing specifically on how immunization coverage relates to disease prevalence within that setting. Findings are interpreted within these boundaries rather than as universal claims applicable to every organization or market.